https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Purpose To evaluate and better characterize the incidence, clinical presentations and risk factors of TOA in postmenopausal women and to evaluate the incidence of underlying malignancy in postmenopausal women with TOA. Methods Electronic based search using Pubmed, EMBASE, Ovid MEDLINE, Google Scholar, and Cochrane Central Register of Controlled Trials. The following medical subject heading (Mesh) terms, keywords, and their combinations were used "tubo-ovarian abscess, pelvic inflammatory disease, menopausal and postmen